A detailed history of Fidelity D & D Bancorp Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Fidelity D & D Bancorp Inc holds 3,381 shares of ABBV stock, worth $598,639. This represents 0.44% of its overall portfolio holdings.

Number of Shares
3,381
Previous 3,426 1.31%
Holding current value
$598,639
Previous $624 Million 7.05%
% of portfolio
0.44%
Previous 0.47%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$154.79 - $180.76 $6,965 - $8,134
-45 Reduced 1.31%
3,381 $580 Million
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $11,826 - $13,475
74 Added 2.21%
3,426 $624 Million
Q4 2023

Jan 12, 2024

SELL
$137.6 - $154.97 $22,291 - $25,105
-162 Reduced 4.61%
3,352 $519 Million
Q3 2023

Nov 30, 2023

BUY
$133.59 - $154.65 $469,435 - $543,440
3,514 New
3,514 $524 Million
Q1 2023

Apr 16, 2024

BUY
$144.61 - $166.54 $10,701 - $12,323
74 Added 2.21%
3,426 $624 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fidelity D & D Bancorp Inc Portfolio

Follow Fidelity D & D Bancorp Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelity D & D Bancorp Inc, based on Form 13F filings with the SEC.

News

Stay updated on Fidelity D & D Bancorp Inc with notifications on news.